Clinical trials for CaverSTIM are underway in Australia, Brazil, and the United States, showing promising results.
Company Description
Comphya is a leader in medical technology that has developed CaverSTIM, the world's first implantable neuromodulator for erectile dysfunction. The device aims to restore erectile function in patients who do not respond to oral medications, utilizing an implantable pulse generator and electrodes to stimulate the necessary nerves.